GlassScriptPhysician profile
Tamra E Lewis
NPI 1639281926
$35,508.09
in general payments reported to CMS, 2019-2025
37 companies · $5,670 in 2025
The $5,670 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,926 · 2020: $6,838 · 2021: $8,241 · 2022: $2,672 · 2023: $1,740 · 2024: $5,421 · 2025: $5,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,235 · Food and Beverage: $4,244 · Travel and Lodging: $2,227 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,235.00 |
| Food and Beverage | $4,243.88 |
| Travel and Lodging | $2,226.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $20,076.39 | 2019-2025 | Speedicath |
| Axonics, INC. | $5,107.64 | 2021-2024 | Axonics, Bulkamid |
| Healthtronics Stone Solutions, LLC | $1,765.00 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Medtronic USA, INC. | $1,546.59 | 2019-2020 | |
| Medtronic, INC. | $965.92 | 2023-2025 | Altaviva, Interstim |
| Ferring Pharmaceuticals INC. | $913.54 | 2019-2025 | Adstiladrin |
| Astellas Pharma US INC | $727.98 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $599.26 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $593.50 | 2020-2025 | |
| Dendreon Pharmaceuticals LLC | $587.34 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $492.25 | 2019-2024 | Erleada |
| Amgen INC. | $344.47 | 2019-2023 | Prolia |
| Boston Scientific Corporation | $327.25 | 2022-2025 | Solyx Sis System |
| Abbvie INC. | $285.65 | 2023-2025 | |
| Myovant Sciences INC. | $202.54 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $133.93 | 2019-2021 | |
| Novo Nordisk INC | $121.77 | 2024 | |
| Allergan, INC. | $98.42 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.54 | 2021-2025 | |
| Bluewind Medical | $79.17 | 2025 | Revi |
| 180 Medical, INC. | $59.98 | 2019-2025 | Gentlecath Glide |
| Olympus America INC. | $48.50 | 2024 | Itind System |
| Travere Therapeutics, INC. | $40.71 | 2019 | |
| Verity Pharmaceuticals INC. | $34.08 | 2022-2025 | Tlando |
| Antares Pharma, INC. | $28.00 | 2020-2021 | |
| Immunitybio, INC. | $26.15 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $23.98 | 2021 | |
| Cardinal Health 108 LLC | $23.21 | 2024 | |
| Teleflex LLC | $21.92 | 2024 | Urolift |
| Endo USA, INC. | $20.83 | 2024 | Xiaflex |
| Laborie Medical Technologies Corp. | $19.59 | 2024 | Goby |
| Avation Medical, INC. | $17.64 | 2024 | Vivally |
| Avadel Specialty Pharmaceuticals, LLC | $17.61 | 2019 | |
| Endo Pharmaceuticals INC. | $16.80 | 2022 | |
| Convatec INC. | $16.70 | 2023 | |
| Pfizer INC. | $16.49 | 2024 | |
| Neotract INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamra Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.